Farmaclair SAS
Farmaclair SAS, headquartered in France, is a prominent player in the pharmaceutical and biotechnology industry, specialising in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Founded in 2005, the company has established a strong presence across Europe and beyond, focusing on innovative solutions that cater to the evolving needs of healthcare providers and patients.
With a commitment to excellence, Farmaclair SAS offers a diverse range of products, including generic medicines and specialised formulations, distinguished by their rigorous quality standards and compliance with international regulations. The company has achieved significant milestones, positioning itself as a trusted partner in the pharmaceutical supply chain, renowned for its reliability and expertise in complex projects.
-4 vs industry average
Farmaclair SAS’s score of 35 is lower than 48% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Farmaclair SAS?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Farmaclair SAS yet.
Farmaclair SAS's reported carbon emissions
Farmaclair SAS, headquartered in France, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is identified as a current subsidiary and does not inherit emissions data from a parent organization. Consequently, there are no specific reduction targets or climate commitments documented, including those from the Science Based Targets initiative (SBTi) or other climate pledges.
As a subsidiary, Farmaclair SAS may align with broader industry standards and practices regarding climate commitments, but specific initiatives or targets have not been disclosed. The lack of reported emissions data suggests an opportunity for the company to establish and communicate its climate strategy more effectively, particularly in the context of increasing global emphasis on sustainability and carbon footprint reduction.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Farmaclair SAS’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Farmaclair SAS yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project